CTIS.eu › Cities › France › Limoges Cedex 1
Limoges Cedex 1
France
190 total trials
83 recruiting
2023-508825-29-00
7
Ventilator-Associated Pneumonia
2024-512236-30-00
5
Community-acquired alveolar pneumonia in children
2024-513724-42-00
10
Medulloblastoma
2024-513889-19-00
5
Multiple Myeloma
2024-515362-13-00
10
Philadelphia-negative myeloproliferative neoplasms are frequent and ch
2024-516257-44-00
4
Multiple myeloma
2024-516328-32-00
4
CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML)
2024-516335-27-00
5
anti-MAG neuropathy
2024-516570-30-00
4
Relapsed/refractory T-cell Acute Lymphoblastic Leukemia
2024-519166-48-01
4
Posterior Urethral Valves
2024-519624-24-00
4
HER3-mutant and HER2-not amplified metastatic breast cancer
2024-519655-28-00
5
Premenopausal patients with high-risk HR-positive/HER2-negative breast
2024-519753-11-00
4
Resectable borderline pancreatic adenocarcinoma
2025-521093-34-00
5
rare disease
2025-521331-36-00
10
Patient with stabilized SSc-ILD (as defined by a decline of FVC ≤ 5%)
2025-521571-30-00
5
Young Adults and adults with R/R B-cell acute lymphoblastic leukemia (
2025-522580-15-00
4
Amyotrophic Lateral Sclerosis (ALS)
2025-523461-17-01
5
LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
2025-523793-16-00
4
Homeostatic iron regulator gene-related hereditary hemochromatosis
2025-524241-27-00
5
Treatment-naїve mantle cell lymphoma (MCL)
2025-524297-42-00
5
CLTI defined as Rutherford category 4 or 5
2024-516527-13-00
11
2026-05-27
Kidney transplantation
2025-522255-25-00
5
2026-05-18
Fallopian Tube Neoplasms
2025-522279-27-00
5
2026-04-02
Newly Diagnosed AML with an NPM1 mutation
Showing 1–24 of 190 trials